167 related articles for article (PubMed ID: 20661070)
1. Colchicine myopathy and neuromyopathy: two cases with different characteristics.
Cantarini L; Volpi N; Galeazzi M; Giani T; Fanti F; Lucherini OM; Aglianò M; Alessandrini C; Giannini F; Magi S; Greco G; Baldari CT; Cimaz R
J Clin Rheumatol; 2010 Aug; 16(5):229-32. PubMed ID: 20661070
[TBL] [Abstract][Full Text] [Related]
2. Colchicine treatment in children with familial Mediterranean fever: is it a risk factor for neuromyopathy?
Işıkay S; Yılmaz K; Yiğiter R; Balat A; Büyükçelik M
Pediatr Neurol; 2013 Dec; 49(6):417-9. PubMed ID: 24084143
[TBL] [Abstract][Full Text] [Related]
3. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin.
van der Velden W; Huussen J; Ter Laak H; de Sévaux R
Neth J Med; 2008 May; 66(5):204-6. PubMed ID: 18490798
[TBL] [Abstract][Full Text] [Related]
4. Colchicine myopathy in a case of familial Mediterranean fever: immunohistochemical and ultrastructural study of accumulated tubulin-immunoreactive material.
Himmelmann F; Schröder JM
Acta Neuropathol; 1992; 83(4):440-4. PubMed ID: 1575022
[TBL] [Abstract][Full Text] [Related]
5. Colchicine-induced myopathy in a teenager with familial Mediterranean fever.
Sayarlioglu M; Sayarlioglu H; Ozen S; Erkoc R; Gul A
Ann Pharmacother; 2003 Dec; 37(12):1821-4. PubMed ID: 14632592
[TBL] [Abstract][Full Text] [Related]
6. Colchicine neuromyopathy: a report of six cases.
Altiparmak MR; Pamuk ON; Pamuk GE; Hamuryudan V; Ataman R; Serdengecti K
Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S13-6. PubMed ID: 12371628
[TBL] [Abstract][Full Text] [Related]
7. About colchicine compliance, resistance and virulence.
Ben-Chetrit E; Aamar S
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S1-3. PubMed ID: 19796522
[No Abstract] [Full Text] [Related]
8. Colchicine is a safe drug in children with familial Mediterranean fever.
Padeh S; Gerstein M; Berkun Y
J Pediatr; 2012 Dec; 161(6):1142-6. PubMed ID: 22738946
[TBL] [Abstract][Full Text] [Related]
9. [Familial Mediterranean fever].
Georgin-Lavialle S; Hentgen V; Stankovic Stojanovic K; Bachmeyer C; Rodrigues F; Savey L; Abbara S; Conan PL; Fraisse T; Delplanque M; Rouet A; Sbeih N; Koné-Paut I; Grateau G
Rev Med Interne; 2018 Apr; 39(4):240-255. PubMed ID: 29526329
[TBL] [Abstract][Full Text] [Related]
10. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
[TBL] [Abstract][Full Text] [Related]
11. Leucopenia resoluted with colchicine in familial mediterranean Fever.
Sakallioglu O
J Pediatr Hematol Oncol; 2012 Mar; 34(2):162. PubMed ID: 22031120
[No Abstract] [Full Text] [Related]
12. [Toxic myopathy with kidney failure as a colchicine side effect ifn familial Mediterranean fever].
Stefanidis I; Böhm R; Hägel J; Maurin N
Dtsch Med Wochenschr; 1992 Aug; 117(33):1237-40. PubMed ID: 1499522
[TBL] [Abstract][Full Text] [Related]
13. Colchicine poisoning: the dark side of an ancient drug.
Finkelstein Y; Aks SE; Hutson JR; Juurlink DN; Nguyen P; Dubnov-Raz G; Pollak U; Koren G; Bentur Y
Clin Toxicol (Phila); 2010 Jun; 48(5):407-14. PubMed ID: 20586571
[TBL] [Abstract][Full Text] [Related]
14. Case report: acute hydrops and spontaneous corneal perforation in a patient with keratoconus treated with colchicine for familial Mediterranean fever.
Hilely A; Kleinmann G
Int Ophthalmol; 2019 Jun; 39(6):1367-1369. PubMed ID: 29713855
[TBL] [Abstract][Full Text] [Related]
15. Colchicine--expanding horizons.
Schattner A
Postgrad Med J; 1991 Mar; 67(785):223-6. PubMed ID: 2062768
[No Abstract] [Full Text] [Related]
16. Transient Pancytopenia and Granulocyte Abnormalities After Suicide Attempt With Colchicine in a Patient With Familial Mediterranean Fever.
Baysal B; Tüfekçi Ö; Erdem M; Yilmaz Ş; Ören H
J Pediatr Hematol Oncol; 2019 Aug; 41(6):489. PubMed ID: 30883459
[No Abstract] [Full Text] [Related]
17. Colchicine: a state-of-the-art review.
Levy M; Spino M; Read SE
Pharmacotherapy; 1991; 11(3):196-211. PubMed ID: 1862011
[TBL] [Abstract][Full Text] [Related]
18. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
Sönmez HE; Batu ED; Bilginer Y; Özen S
Clin Rheumatol; 2017 Feb; 36(2):421-425. PubMed ID: 27679472
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?
Ben-Chetrit E; Ben-Chetrit A; Berkun Y; Ben-Chetrit E
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):143-8. PubMed ID: 20191511
[TBL] [Abstract][Full Text] [Related]
20. Colchicine-induced myoneuropathy with myotonia in a patient with familial Mediterranean fever.
Tunç A; Gürsoy AE; Güzel V; Gökçal E; Yıldız GB
Acta Neurol Belg; 2020 Jun; 120(3):687-688. PubMed ID: 30604339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
